Stay updated with breaking news from Erick Rowinsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen (NASDAQ:BIIB – Get Free Report) announced its quarterly earnings results on Wednesday. The biotechnology company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $3.45 by $0.22, Briefing.com reports. Biogen had a return on equity of 14.91% and a net margin of 11.81%. The company had revenue of $2.29 billion […]
Biogen (NASDAQ:BIIB – Get Free Report) had its price target lowered by equities research analysts at Barclays from $215.00 to $200.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “equal weight” rating on the biotechnology company’s stock. Barclays‘s target price points to a potential downside of 1.15% from the […]
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) saw strong trading volume on Wednesday . 904,201 shares traded hands during mid-day trading, a decline of 22% from the previous session’s volume of 1,159,178 shares.The stock last traded at $204.63 and had previously closed at $193.18. Wall Street Analyst Weigh In Several equities analysts have […]
Biogen Inc. (NASDAQ:BIIB – Get Free Report) shares saw strong trading volume on Wednesday . 904,201 shares changed hands during mid-day trading, a decline of 22% from the previous session’s volume of 1,159,178 shares.The stock last traded at $204.63 and had previously closed at $193.18. Wall Street Analyst Weigh In BIIB has been the topic […]
Biogen (NASDAQ:BIIB – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $15.00-16.00 for the period, compared to the consensus earnings per share estimate of $15.49. The company issued revenue guidance of decline low- to mid-single digits, compared to the consensus revenue estimate of $9.47 billion. […]